MARQUEE Trial - Dr. Ron Burkes - 100351


MARQUEE Trial - Dr. Ron Burkes

Description: For more updates visit

Dr. Ron Burkes with commentary on Abstract #3410: A randomized, double-blind, placebo-controlled, phase 3 trial of tivantinib (ARQ 197) plus erlotinib versus placebo plus erlotinib in previously treated patients with locally advanced or metastatic, non-squamous, non-small-cell lung cancer (NSCLC).
Shared By : oncologyeducation
Posted on : 10/07/13
Added : 5 years ago
Category : General